← ANALYSTS · TIPRANKS

Madison Elsaadi · B. Riley Securities

#984among 12,504 TipRanks analysts★★★★★★★★★★
Hits 54% 25 of 46 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating +35.6% Over a year after the rating, TipRanks’ measure
Our companies rated now 10 Buy / hold / sell: 10 / 0 / 0
Upside of the analyst’s targets +182.7% Average over 10 current targets, to the last price
The market’s answer to the ratings +2.7% Day-0 move against SPY in the rating’s direction, average over 7 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Oct 12on TipRanks 09:10 WVEIWMWave Life Sciences · $629M Reiterated Buy $22.00 +602.9% −5.1%next day −4.3%
Oct 2on TipRanks 08:50 OBIOIWMOrchestra BioMed Holdings · $339M Reiterated Buy $11.00 +101.8% −7.0%next day +0.7% · 5 days −1.2%
Sep 18on TipRanks 08:10 ANIKIWMAnika Therapeutics · $277M Initiated Buy $21.00 → $23.00+9.5% +15.1% −1.2%next day −2.1% · 5 days −3.4%
Sep 14on TipRanks 07:25 CAPRIWMCapricor Therapeutics · $423M Upgrade Buy $5.00 → $21.00+320.0% +213.0% +5.7%next day −2.4% · 5 days −0.9%
Aug 10on TipRanks 08:35 VNDAIWMVanda · $256M Initiated Buy $17.00 → $12.00−29.4% +197.8% +0.4%next day −1.5% · 5 days +4.8%
Aug 5on TipRanks 08:55 ARWRArrowhead Pharmaceuticals · $8.2B Reiterated Buy $123 +120.0% −2.8%next day −1.1% · 5 days 0.0%
Jul 13on TipRanks 08:21 SPRBIWMSpruce Biosciences · $119M Initiated Buy $160 +303.5% −2.6%next day −4.5% · 5 days −7.1%
Jun 25on TipRanks Jun 26 13:30 ETONIWMEton Pharmaceuticals · $1.5B Reiterated Buy $40.00 −20.5% +2.3%next day +3.3% · 5 days +6.3%
May 13on TipRanks May 14 06:35 OVIDIWMOvid Therapeutics · $428M Reiterated Buy $5.00 +132.6% −3.0%next day −0.8% · 5 days −14.5%
Apr 30on TipRanks 09:35 IRDIWMOpus Genetics · $337M Reiterated Buy $9.00 → $10.00+11.1% +160.4% +8.4%next day +0.3% · 5 days +3.1%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗